Severe dermographism after topical therapy with diphenylcyclopropenone for alopecia universalis.
We describe here a 19-year-old Japanese man with an 11-year history of alopecia universalis, who, after the 1st application of a 0.003% diphenylcyclopropenone (DPCP) solution to the whole scalp, developed acute contact dermatitis at the test site, together with widespread severe dermographism. Every 3 weeks, persistence of the severe urticarial reaction and efficacy of treatment were monitored by constant pressure stimuli in a series of pressure tests, and subsequently evaluated by laser Doppler flowmetry (LDF). Although, on pressure tests, the urticarial response was found to significantly improve after starting treatment, erythematous responses continued to appear for nearly 3 months. The persistent course of these side-effects in our patient strongly suggests that precautions must currently be taken in the therapeutic use of potent sensitizers such as DPCP.
Skrebova
N
N
Department of Dermatology, The University of Tokushima School of Medicine, Japan.
Nameda
Y
Y
Takiwaki
H
H
Arase
S
S
D000287:Administration, Topical; D000328:Adult; D000505:Alopecia / Q000175:diagnosis / Q000188:drug therapy*; D003521:Cyclopropanes / Q000008:administration & dosage / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D017078:Laser-Doppler Flowmetry; D008297:Male; D011379:Prognosis; D012536:Scalp Dermatoses / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D012720:Severity of Illness Index; D014581:Urticaria / Q000139:chemically induced / Q000175:diagnosis
D003521:Cyclopropanes; C029402:diphenylcyclopropenone